Yourgene Health’s (YGEN) Corporate Rating Reiterated at FinnCap

Share on StockTwits

Yourgene Health (LON:YGEN)‘s stock had its “corporate” rating reissued by investment analysts at FinnCap in a research report issued to clients and investors on Tuesday.

YGEN stock opened at GBX 9.30 ($0.12) on Tuesday.

About Yourgene Health

Yourgene Health Plc, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome.

Featured Story: What strategies should day traders use to execute a trade?

Receive News & Ratings for Yourgene Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yourgene Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Energy Transfer LP Unit  & Kinder Morgan  Critical Review
Energy Transfer LP Unit & Kinder Morgan Critical Review
ForceField Energy  vs. Rogers  Head-To-Head Contrast
ForceField Energy vs. Rogers Head-To-Head Contrast
Contrasting Oppenheimer  & SEI Investments
Contrasting Oppenheimer & SEI Investments
Fifth Third Bancorp  Upgraded to “Hold” at BidaskClub
Fifth Third Bancorp Upgraded to “Hold” at BidaskClub
Huntington Bancshares  Raised to Sell at BidaskClub
Huntington Bancshares Raised to Sell at BidaskClub
Aldeyra Therapeutics, Inc  Receives Average Rating of “Buy” from Analysts
Aldeyra Therapeutics, Inc Receives Average Rating of “Buy” from Analysts


Leave a Reply

 
© 2006-2019 Zolmax.